학술논문

Long-term outcomes of tepotinib in patients with MET exon 14 skipping NSCLC from the VISION study.
Document Type
Article
Source
Journal of Clinical Oncology; 2023 Supplement 16, Vol. 41, p9060-9060, 1p
Subject
Language
ISSN
0732183X